[ad_1] A panel of experts decided Friday not to recommend the United States Medicines Agency (FDA) to authorize a new treatment for Alzheimer’s disease, research on which has been at a standstill for decades, according to AFP. After a lengthy examination of the file, the eleven members of the commission …
Read More »